Current Hematologic Malignancy Reports

Papers
(The H4-Index of Current Hematologic Malignancy Reports is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Monoclonal Gammopathy-Associated Neuropathy137
Financial Toxicity in Patients with Hematologic Malignancies: a Review and Need for Interventions33
Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations26
Targeting RUNX1 Germline Variants: Agents Under Investigation21
Telomere Biology Disorder: A Focus on Gastrointestinal and Hepatic Manifestations20
Management of Chronic Myeloid Leukemia in Children and Young Adults18
Mutant Calreticulin in MPN: Mechanistic Insights and Therapeutic Implications18
Value in Myeloma Care: Myth or Reality17
Correction to: Treatment of Myelodysplastic Syndromes for Older Patients: Current State of Science, Challenges, and Opportunities17
Splicing Factor Mutations in Chronic Myelomonocytic Leukemia: Biological Consequences and Therapeutic Implications17
Contemporary Updates in the Prevention and Treatment of Graft-Versus-Host Disease17
Clonal Hematopoiesis in Myeloproliferative Neoplasms Confers a Predisposition to both Thrombosis and Cancer16
Targeting Apoptosis in ALL15
Transplantation and Cellular Therapy for Older Adults—The MSK Approach14
Allogeneic Transplant for CMML14
0.15260100364685